Tokyo, July 22 (Jiji Press)–The Japanese Central Social Insurance Medical Council, which advises the health minister, on Wednesday approved the application of public health insurance to RiHeart, a cardiac muscle cell sheet that uses induced pluripotent stem, or iPS, cells, effective on